Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.
Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee S. et al, (2024), eLife, 12
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Safety and efficacy of primaquine in patients withPlasmodium vivaxmalaria from South Asia: a systematic review and individual patient data meta-analysis
Verma R. et al, (2023), BMJ Global Health, 8, e012675 - e012675
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Mehdipour P. et al, (2023), Malaria Journal, 22
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
Artemisinin resistance and malaria elimination: Where are we now?
Hanboonkunupakarn B. et al, (2022), Frontiers in Pharmacology, 13
Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia
Cutts JC. et al, (2022), The Journal of Infectious Diseases, 226, 324 - 331
Correction: Yuhana et al. Rickettsial Infections Are Neglected Causes of Acute Febrile Illness in Teluk Intan, Peninsular Malaysia. Trop. Med. Infect. Dis. 2022, 7, 77
Yuhana MY. et al, (2022), Tropical Medicine and Infectious Disease, 7, 134 - 134
Rickettsial Infections Are Neglected Causes of Acute Febrile Illness in Teluk Intan, Peninsular Malaysia
Yuhana MY. et al, (2022), Tropical Medicine and Infectious Disease, 7, 77 - 77
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
Adam I. et al, (2022), Wellcome Open Research, 7, 136 - 136
Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study
O’Flaherty K. et al, (2022), Frontiers in Cellular and Infection Microbiology, 12